Open an account

111

YI · NASDAQ

$3.13−$0.005 (−0.16%)TodayMarket closed ·
Prev close $3.14

About YI

111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2018-09-12. The firm mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The firm also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The firm mainly conducts its business in the domestic market.

Employees
1,063
Headquarters
Shanghai, Shanghai
Listed
Sep 12, 2018
Sector
Consumer Staples
Industry
Consumer Staples Distribution & Retail
Website
corporate.111.com.cn

YI key statistics

Market cap
33.87M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
12.92K
Volume
9.37K
Open price
$3.15
High today
$3.20
Low today
$3.13
52 Week high
$11.17
52 Week low
$2.48

111 (YI) at a glance

As of Oct 20, 2026, 111 (YI) shares are priced at $3.13, giving the company a market cap of 33.87M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $3.13 and $3.20. The current price is 0.0% above the day's low and 2.2% below its high.

Volume so far is 9.37K shares, below the average of 12.92K shares a day.

Over the past year 111 has ranged from $2.48 to $11.17, and now sits 7% of the way up that range.

111 met or beat analyst EPS estimates in 0 of the last 6 quarters. In Q3 FY24 it reported -$0.145 per share against an estimate of $0.00.

YI earnings

Earnings per share, reported against the analyst estimate

Didn’t beat the estimate in any of the last 6 quarters.

  1. Q1 FY23: reported -$0.4293 per share against an estimate of $0.00
  2. Q3 FY23: reported -$1.14 per share against an estimate of $0.00
  3. Q4 FY23: reported -$2.45 per share against an estimate of $0.00
  4. Q1 FY24: reported -$0.1448 per share against an estimate of $0.00
  5. Q2 FY24: reported -$0.1419 per share against an estimate of $0.00
  6. Q3 FY24: reported -$0.145 per share against an estimate of $0.00

YI news

  • Press releasePRNewswire

    111, Inc. Announces Establishment of the Special Committee

  • Akanksha Bakshi

    China's 111 Inc. Gets Buyout Proposal From Co-Founders in Going-Private Push

  • Press releasePRNewswire

    111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company

  • Press releasePRNewswire

    111, Inc. Announces Second Quarter 2026 Unaudited Financial Results

  • Press releasePRNewswire

    111, Inc. Announces First Quarter 2026 Unaudited Financial Results

  • Press releasePRNewswire

    111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

  • Press releasePRNewswire

    111, Inc. Announces Third Quarter 2025 Unaudited Financial Results

  • 12 Consumer Staples Stocks Moving In Thursday's After-Market Session

Similar companies

Companies in the same industry as 111

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.